Event Overview

Studying layers of cells grown on flat surfaces leaves a lot to be desired, as cellular responses and gene expression change when cells are not in their native, 3-D arrangements. Researchers develop organoids from primary cell lines or stem cells, and these structures are similar in architecture to primary tissue, which makes them relevant models of in vivo conditions. Scientists use organoids to study many areas of human biology, including toxicology, infection, and cancer. Join this webinar, brought to you by The Scientist, to hear how researchers use human cerebral and tumor-derived organoids to better mimic the state of living tissue for drug development and infection studies.

Topics to be Covered
  • Human cerebral organoid applications for prion disease
  • Insights from the Human Cancer Models Initiative
Thursday, April 30, 2020
2:30 - 4:00 PM, Eastern Standard Time


Cathryn Haigh, PhD
Chief, Prion Cell Biology Unit
Laboratory of Persistent Viral Diseases
National Institute of Allergy and Infectious Diseases
Division of Intramural Research
Rocky Mountain Laboratories
National Institutes of Health

Daniela S. Gerhard, PhD
Director, the Human Cancer Model Initiative
Director, Office of Cancer Genomics
National Cancer Institute
National Institutes of Health


Register Now

Using 3-D Organoids to Answer Questions About Human Health

You must have Javascript and Cookies enabled to access this webcast.

Information you provide will be held in confidence and will be shared with the sponsoring vendor(s) of this webinar. We may use the information to contact you about your account and to let you know about related programs and products; you may opt-out at any time. This allows The Scientist to keep these webinars free of charge for our readers.